Zusammenfassung
Das sympathische Nervensystem befähigt durch seine Überträgerstoffe, Noradrenalin und Adrenalin, den Organismus, auch unter extremen Bedingungen lebenswichtige Funktionen und die Versorgung mit Stoffwechselenergie aufrechtzuerhalten. So schließen Cannon et al. (1924) aus ihrer klassischen Untersuchung der Abwehrmechanismen, die dem Organismus bei lebensbedrohendem Glucosemangel zur Verfügung stehen, daß das adrenerge System ein bemerkenswertes Beispiel für eine automatische Regelung darstellt. Bereits die klinischen Symptome der Hypoglykämie, wie Tachykardie, Blässe, Schweißausbruch und Pupillenerweiterung, weisen auf eine Erregung im sympathischen Bereich hin. Von den Autoren wurde die Konzentration der Katecholamine im Blut an der Frequenz des denervierten Herzens gemessen. Die Herzfrequenz stieg an, sobald der Blutzucker auf hypoglykämische Werte abfiel, und diese Reaktion wurde durch Glucose oder durch operative Entfernung der Nebennieren beseitigt. Damit war der Beweis erbracht, daß eine Hypoglykämie eine Aktivierung des Sympathicus und eine Abgabe von Katecholaminen aus dem Nebennierenmark auslöst. Dadurch wird Glucose aus der Leber mobilisiert und die Gefahr der Hypoglykämie abgewendet. Diese Funktion des sympathischen Systems ist auch in Versuchen an operativ sympathektomierten Tieren deutlich geworden. Die Blutglucose-Konzentration sympathektomierter Katzen unterschied sich nicht von Kontrollwerten, und auch auf kleine Insulindosen, die keine hypoglykämischen Symptome auslösten, reagierten die operierten Tiere normal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abramson, E.A., Arky, R.A.: Role of beta-adrenergic receptors in counterregulation to insulin induced hypoglycemia. Diabetes 17, 141–146(1968).
Ahlquist, R.P.: A study of the adrenergic receptors. Amer. J. Physiol. 153, 586–600(1948).
Altszuler, N.R., Steele, L, Ratinger, I., Bodo, R.C. de: Glucose metabolism and plasma insulin level during epinephrine infusion in the dog. Amer. J. Physiol. 212, 677–682(1967).
Armstrong, D.T., Steele, R., Altzuler, N.R., Dunn, A., Bishop, I.S., Bodo, R.C.D.E.: Regulation of plasma free fatty acid turnover. Amer. J. Physiol. 201, 9–15(1961).
Batzri, S., Sellinger, Z., Schramm, M., Robinovitsch, M. R.: Potassium release mediated by the epinephrine a receptor in rat parotid. J. biol. Chem. 248, 361–368(1973).
Baum, D., Porte, D., jr.: Alpha-adrenergic inhibition of immunoreactive insulin release during deep hypothermia. Amer. J. Physiol. 221, 303–311(1971).
Belleau, B.: Stereochemistry of adrenergic receptors: newer concepts on the molecular mechanism of action of catecholamines and antiadrenergic drugs at the receptor level. Ann. N.Y. Acad. Sci. 139, 580–605(1967).
Beviz, A., Lundholm, L., Mohme-Lundholm, E., Svedmyr, N.: The effect of adrenaline on the carbohydrate metabolism in striated muscle. Acta physiol. scand. 69, 213–217(1967).
Bishop, J.S., Larner, J.: Rapid activation-inactivation of liver uridine diphosphate glucose-glycogen transferase and phosphorylase by insulin and glucagon in vivo. J. biol. Chem. 242, 1354–1356(1967).
Bitensky, M. W., Gorman, R.E., Neufeld, A.H.: Selective effect of insulin on hepatic epinephrine responsive adenyl cyclase activity. Endocrinology 90, 1331–1335(1972).
Bitensky, M.W., Russel, V., Blanco, M.: Independent variation of glucagon and epinephrine responsive components of hepatic adenylcyclase as a function of age, sex, and steroid hormones. Endocrinology 86, 154–159(1970).
Blecher, M., Merlino, N.S., Roane, J.T., Flynn, P.D.: Independence of the effects of epinephrine, glucagon and adenocorticotropin on glucose utilisation from those on lipolysis in isolated rat adipose cells. J. biol. Chem. 244, 3423–3429(1969).
Bloom, B.M., Goldman, I.M.: The nature of catecholamine-adenine mononucleotide interactions in adrenergic mechanisms. Advanc. Drug Res. 3, 121–169(1966).
Brewsher, P.D., Ashmore, J.: Ketogenic and lipolytic effect of glucagon on liver. Biochem. biophys. Res. Commun. 24, 431–436(1966).
Brody, M.J., Dixon, M.L.: Vascular reactivity in experimental diabetes mellitus. Circulat. Res. 14, 494–501(1964).
Burn, J.H., Hutcheon, D.E., Parker, R.H.O.: Adrenaline and noradrenaline in the suprarenal medulla after insulin. Brit. J. Pharmacol. 5, 417–423(1950).
Burns, J.J., Colville, K.J., Lindsay, L.A., Salvador, R.A.: Blockade of some metabolic effects of catecholamines by N-isopropyl-methoxamine. J. Pharmacol, exp. Ther. 144, 163–171(1964).
Buse, M. G., Johnson, A.H., Kuperminc, D., Buse, J.: Effect of alpha adrenergic blockade on insulin secretion in man. Metabolism 19, 219–225(1970).
Butcher, R. W., Ho, R.J., Meng, H.C., Sutherland, E. W.: Adenosine-3′, 5′-monophosphate in biological material. II. The measurement of adenosine-3′, 5′-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J. biol. Chem. 240, 4515–4525(1965).
Byers, S.O., Friedman, M.: Insulin hypoglycemia enhanced by beta adrenergic blockade. Proc. Soc. exp. Biol. (N.Y.) 122, 114–115(1966).
Cahill, G. F., Leboeuf, B., Flinn, R.B.: Studies on adipose tissue in vitro. VI. Effect of epinephrine on glucose metabolism. J. biol. Chem. 235, 1246–1250(1960).
Cannon, W. B., Mciver, A.B., Bliss, S. W.: Studies on the conditions of activity in endocrine glands. XIII. A sympathetic and adrenal mechanism for mibilizing sugar in hypoglycemia. Amer. J. Physiol. 69, 46–66(1924).
Cerasi, E., Luft, R., Efendic, S.: Effect of adrenergic blocking agents on insulin response to glucose infusion in man. Acta endocr. (Kbh.) 69, 335–346(1972).
Chesney, T.M.C.C., Schofield, J. G.: Studies on the secretion of pancreatic glucagon. Diabetes 18, 627–632(1969).
Cheung, W. Y., Williamson, J. R.: Kinetics of adenosine monophosphate changes in rat heart following epinephrine administration. Nature (Lond.) 207, 979–980(1965).
Claasen, V., Noach, E.L.: Dichloro-isuprel inhibition of sympathomimetic hyperglycaemia. Arch. int. Pharmacodyn. 126, 332–340(1960).
Cleveland, D., Davis, L.: Further studies on the effect of hypothalamic lesions upon carbohydrate metabolism. Brain 59, 459–465(1936).
Cohen, G., Holland, B., Sha, J., Goldenberg, M.: Plasma concentrations of epinephrine and norepinephrine during intravenous infusions in man. J. clin. Invest. 38, 1935–1941(1959).
Coore, H. G., Randle, P. J.: Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93, 66–78(1964).
Cori, C.F., Cori, G. T., Buchwald, K. W.: The mechanism of epinephrine action. Amer. J. Physiol. 93, 273–283(1930).
Craig, J. W., Rall, T. W., Larner, J.: The influence of insulin and epinephrine on adenosine 3′, 5′-phosphate and glycogen transferase in muscle. Biochim. biophys. Acta (Amst.) 177, 213–219(1969).
Crane, R.K., Sols, A.: The association of hexokinase with particulate fractions of brain and other tissue homogenates. J. biol. Chem. 203, 273–292(1953).
Crespin, S.R., Greenough, W. R., Steinberg, D.: Stimulation of insulin secretion by infusion of free fatty acids. J. clin. Invest. 48, 1934–1943(1969).
Cseuz, R., Wenger, T.L., Kunos, G., Szentivanyi, M.: Changes of adrenergic reaction pattern in experimental diabetes mellitus. Endocrinology 93, 752–755(1973).
Curry, D.L., Curry, K.P.: Hypothermia and insulin secretion. Endocrinology 87, 750–755(1970).
Deckert, R., Lauridsen, U.B., Madsen, S.N., Deckert, M.: Serum insulin following isoprenaline in normal and diabetic persons. Horm. Metab. Res. 4, 229–232(1972).
Duner, H.: The influence of the blood glucose level on the secretion of adrenaline and noradrenaline from the suprarenal. Acta physiol. scand. 28, Suppl. 102, 1–77(1953).
Ellis, S.: The metabolic effects of epinephrine and related amines. Pharmacol. Rev. 8, 485–562(1956).
Esterhuizen, A. C., Spriggs, T.L.B., Lever, J. D.: Nature of islet cell innervation in the cat pancreas. Diabetes 17, 33–36(1968).
Euler, U.S. von: The nature of adrenergic nerve mediators. Pharmacol. Rev. 3, 247–277(1951).
Euler, U.S. von, Luft, R.: Effect of insulin on urinary excretion of adrenaline and noradrenaline. Metabolism 1, 528–532(1952).
Exton, J. H., Friedman, N., Wong, E.H.A., Brineaux, J. P., Corbin, J. D., Park, C.R.: Interaction of glucocorticoids with glucagon and epinephrine in the control of gluconeogenesis and glycogenos is in liver and of lipolysis in adipose tissue. J. biol. Chem. 247, 3579–3588(1972).
Exton, J. H., Malette, L.E., Jefferson, L.S., Wong, E.H.A., Friedman, N., Miller, T.B., Park, C.R.: The hormonal control of hepatic gluconeogenesis. Recent Progr. Hormone Res. 26, 411–461(1970).
Exton, J. H., Park, C.R.: Control of gluconeogenesis in liver. J. biol. Chem. 242, 2622–2636(1967).
Fine, M.B., Williams, R.H.: Effects of fasting, epinephrine and glucose, and insulin on hepatic uptake of nonesterified fatty acids. Amer. J. Physiol. 199, 403–406(1960).
Fleming, W.W., Kenny, A.D.: The effect of fasting on the hyperglycemic response to catecholamines in rats. Brit. J. Pharmacol. 22, 267–274(1964).
Furchtgott, R. F.: The pharmacological differentiation of adrenergic receptors. Ann. N.Y. Acad. Sci. 139, 553–570(1967).
Goldfien, A.: Effects of glucose deprivation on the sympathetic outflow to the adrenal medulla and adipose tissue. Pharmacol. Rev. 18, 303–311(1966).
Gordon, R.S., Cherkes, A.: Production of unesterified fatty acids from isolated rat adipose tissue incubated in vitro. Proc. Soc. exp. Biol. (N.Y.) 97, 150–151(1958).
Hasselblatt, A.: Interrelations between lipid and carbohydrate metabolism. Naunyn-Schmiedebergs. Arch. Pharmak. 269, 331–346(1971).
Haugaard, N., Hess, M.E.: Actions of autonic drugs on phosphorylase activity and function. Pharmacol. Rev. 17, 27–69(1965).
Heimberg, M., Fizette, N.B.: The action of norepinephrine on the transport of fatty acids and triglycerides by the isolated perfused rat liver. Biochem. Pharmacol. 12, 392–394(1968).
Heimberg, M., Weinstein, I., Kohout, M.: The effect of glucagon, dibutyryl cyclic adenosine 3′-, 5′-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J. biol. Chem. 244, 5131–5139(1969).
Himms-Hagen, J.: Sympathetic regulation of metabolism. Pharmacol. Rev. 19, 367–461(1967).
Huijing, F.R., Larner, J.: On the mechanism of action of adenosine-3′-5′-cyclophosphate. Proc. nat. Acad. Sci. (Wash.) 56, 647–653(1966).
Issekutz, B., Allen, M.: Effect of catecholamines and methylprednisolone on carbohydrate metabolism of dogs. Metabolism 21, 48–59(1972).
Kipnis, D.M., Helmreich, E., Cori, C. F.: Studies of tissue permeability. IV The distribution of glucose between plasma and muscle. J. biol. Chem. 234, 165–170(1959).
Kosaka, K., Ide, T., Kuzuya, T., Miki, E., Kuzuya, N., Okinaka, S.: Insulin like activity in pancreatic vein blood after glucose loading and epinephrine hyperglycemia. Endocrinology 75, 9–14(1964).
Kukovetz, W.R., Hess, M.E., Shanfield, J., Haugaard, N.: The action of sympathomimetic amines on isometric contraction and phosphorylase activity of the isolated rat heart. J. Pharmacol. exp. Ther. 127, 122–127(1959).
Kuo, J. F., Renzo, E.C. de: A comparison of the effects of lipolytic and antilipolytic agents on adenosine 3′-5′-monophosphate levels in adipose cells as determined by prior labeling with adenine-C-8-14C. J. biol. Chem. 244, 2252–2260(1969).
Lands, A.M., Arnold, A., McAuliff, J. P., Luduena, F. P., Brown, T. G.: Differentiation of receptor systems activated by sympathomimetic amines. Nature (Lond.) 214, 597–598(1967).
Loubatieres, A., Mariani, M.M., Chapal, J., Houareau, M.H., Rondot, A.M.: Action nocive de l’adrenaline pur la structure histologique des ilots de Langerhans du pancreas. Action protective de la dihydroergotamine. Diabetologia 1, 13–20(1965).
Madison, L.L., Seyffert, W.A., Unger, R. H., Barker, B.: Effect of plasma free fatty acids on plasma glucagon and serum insulin concentration. Metabolism 17, 301–304(1968).
Mayer, S., Moran, N.C., Fain, J.: The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J. Pharmacol, exp. Ther. 134, 18–27(1961).
Nathanielsz, P.W.: Effect of cold (4° C) on catecholamine excretion in the diabetic rat and its relation to autonomic neuropathy. Diabetes 18, 625–626(1969).
Nestel, P.J., Steinberg, D.: Fate of palmitate and of linoleate perfused through the isolated rat liver at high concentrations. J. Lipid Res. 4, 461–469(1963).
Newsholme, E.A., Randle, P.J., Manchester, K. L.: Regulation of glucose uptake by the muscle. 7. Effects of fatty acids, ketone bodies and pyruvate, and diabetes and starvation, hypophysectomy and adrenalectomy on concentration of hexose phosphates, nucleotides, and inorganic phosphate. Biochem. J. 93, 641–651(1964).
Northrop, G., Ryan, W.G., Schwartz, T.B.: Propranolol-induced insulin release in isolated rat islets of Langerhans. Diabetes 22, 91–93(1973). ØYE, J.: The action of adrenaline in cardiac muscle. Dissociation between phosphorylase activation and inotropic response. Acta physiol. scand. 65, 251–258(1965).
Park, C.R.: Diskussionsbemerkung; IDF-Congress, Stockholm, 1967.
Park, C.R., Exton, J. H.: Glucagon and metabolism of glucose. In: Glucagon (Lefebvre, P.J., Unger, R. H., eds.), p. 77–108. Oxford: Pergamon Press 1972.
Porte, D., jr.: A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. clin. Invest. 46, 86–94(1967a).
Porte, D., jr.: Beta-adrenergic stimulation of insulin release in man. Diabetes 16, 150–155(1967b).
Porte, D., jr.: Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch. intern. Med. 123, 252–260(1969).
Porte, D., jr., Graber, A.L., Kuzuya, T., Williams, R. H.: The effect of epinephrine on immunoreactive insulin levels in man. J. clin. Invest. 45, 228–236(1966).
Posner, J.R., Stern, R., Krebs, E.G.: Effects of electrical stimulation and epinephrine on muscle phosphorylase phosphorylase b kinase, and adenosine 3′,-5′-phosphate. J. biol. Chem. 240, 982–985(1965).
Rappaport, A.M., Kawamura, T., Davidson, J. K., Lin, B.J., Ohira, S., Zeigler, M., Coddling, J.A., Hendersen, J., Haist, R.E.: Effects of hormones and of blood flow on insulin output of isolated pancreas in situ. Amer. J. Physiol. 221, 343–348(1971).
Robertson, R.P., Porte, D., jr.: Adrenergic modulation of basal insulin secretion in man. Diabetes 22, 1–8(1973a).
Robertson, R.P., Porte, D., jr.: The glucose receptor-a defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J. clin. Invest. 52, 870–876(1973b).
Robison, G.A., Butcher, R.W., Sutherland, E.W.: Adenylcyclase as an adrenergic receptor. Ann. N.Y. Acad. Sci. 139, 703–723(1967).
Robison, G.A., Butcher, R.W., Sutherland, E.W.: Cyclic AMP, New York, London: Academic Press 1971.
Rosell-Perez, M., Larner, J.: Studies on UDPG-a-glucan transglucosylase. V. Two forms of the enzyme in dog sceletal muscle and their interconversion. Biochemistry (Wash.) 3, 81–88(1964).
Schalch, D.S., Kipnis, D.M.: The impairment of carbohydrate tolerance by elevated plasma free fatty acids. J. clin. Invest. 43, 1283–1284(1964).
Schlossberg, T., Sawyer, M.E.M., Bixby, E.M.: Studies of homeostasis in normal, sympathectomized and ergotaminized animals. III. The effect of insulin. Amer. J. Physiol. 104, 190–194(1933).
Schonfeld, G., Kipnis, D.M.: Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragma. Amer. J. Physiol. 215, 513–522(1968).
Shipp, J. C., Opie, L. H., Challoner, D.R.: Interactions between carbohydrate and fatty acid metabolism of isolated perfused rat heart. Metabolism 13, 852–867(1964).
Sokal, J. E., Sarcione, E. J.: Failure of physiological concentrations of epinephrine to affect glycogen levels in the isolated rat liver. Nature (Lond.) 204, 881–883(1964).
Somogyi, M.: Mechanism of epinephrine hyperglycemia. Endocrinology 49, 774–781(1951).
Steinberg, D., Nestel, P.J., Bütcher, E.R., Thompson, R. H.: Calorigenic effect of norepinephrine correlated with plasma free fatty acid turnover and oxidation. J. clin. Invest. 43, 167–176(1964).
Sutherland, E.W., Rall, T.W.: The relation of adenosine 3′-5′-phosphate and phosphorylase to the action of catecholamines and other hormones. Pharmacol. Rev. 12, 265–299(1960).
Tarrant, M. E., Thompson, R. H. S., Wright, P. H.: Some aspects of lipid metabolism in rats treated with antiinsulin serum. Biochem. J. 84, 6–10(1962).
Tolbert, M. E. M., Bütcher, F. R., Fain, J. N.: Lack of correlation between catecholamine effects on cyclicadenosine 3′-5′-monophosphate and gluconeogenesis in isolated rat liver cells. J. biol. Chem. 248, 5686–5692(1973).
Verner, J. V., Blackard, W.G., Engel, F.L.: Some factors modifying the actions of hormones on glucose uptake by adipose tissue in vitro. Endocrinology 70, 420–428(1962).
Walaas, O., Walaas, E.: Effect of epinephrine on rat diaphragm. J. biol. Chem. 187, 769–776(1950).
Westermann, E.: Sympathicus und Fettstoffwechsel. Acta neuroveg. (Wien) 30, 19–29(1967).
White, J.E., Engel, F.L.: A lipolytic action of epinephrine and norepinephrine on rat adipose tissue in vitro. Proc. Soc. exp. Biol. (N.Y.) 99, 375–378(1958).
Wilber, J. P., Turtle, J. R., Crane, N.A.: Inhibition of insulin secretion by a phaeochromocytoma. Lancet 1966 II, 733.
Wright, P. H., Malaisse, W.J.: Effects of epinephrine, stress and excercise on insulin secretion by the rat. Amer. J. Physiol. 214, 1031–1034(1968).
Wulff, D.E.H., Hers, H. G.: The role of glucose, glucagon and glucocorticoids in the regulation of liver glycogen synthesis. Europ. J. Biochem. 6, 558–564(1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hasselblatt, A. (1975). Stoffwechselwirkungen der Katecholamine. In: Cerasi, E., et al. Diabetes mellitus · A. Handbuch der inneren Medizin, vol 7 / 2 / A. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66033-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-66033-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66034-4
Online ISBN: 978-3-642-66033-7
eBook Packages: Springer Book Archive